Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haugan

Showing results (281-290 of 313) with videos related to

Pageof 32
Sort By:
Heart Rhythm|July 19, 2015
Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit heartsYu-Cheng Hsieh, Jiunn-Cherng Lin, Chen-Ying Hung, et al.
Circulation. Arrhythmia and Electrophysiology|July 18, 2024
Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP StudyLucas Yixi Xing, Søren Højberg, Derk W Kriegerg, et al.
Plos One|July 19, 2023
Treatment-induced increase in total body potassium in patients at high risk of ventricular arrhythmias; a randomized POTCAST substudyUlrik Winsløw, Tharsika Sakthivel, Chaoqun Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2009
The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis modelEric I Rossman, Kun Liu, Gwen A Morgan, et al.
American Heart Journal|August 24, 2021
Atrial fibrillation burden and cognitive decline in elderly patients undergoing continuous monitoringMathias Pinto Bonnesen, Søren Zöga Diederichsen, Jonas L Isaksen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 18, 2021
Comparison of the three-level and the five-level versions of the EQ-5DAnne Simone Juhl Christiansen, Marie Louise Sletskov Møller, Christian Kronborg, et al.
Plos One|June 3, 2022
Potential role of conventional and speckle-tracking echocardiography in the screening of structural and functional cardiac abnormalities in elderly individuals: Baseline echocardiographic findings from the LOOP studyFlemming Javier Olsen, Søren Zöga Diederichsen, Peter Godsk Jørgensen, et al.
Journal of the American College of Cardiology|October 29, 2025
Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP StudyOliver B Vad, Søren Z Diederichsen, Lucas Y Xing, et al.
Circulation. Cardiovascular Imaging|March 5, 2024
Left Atrial Strain Predicts Subclinical Atrial Fibrillation Detected by Long-term Continuous Monitoring in Elderly High-Risk IndividualsFlemming Javier Olsen, Søren Zöga Diederichsen, Peter Godsk Jørgensen, et al.
Cerebrovascular Diseases (Basel, Switzerland)|December 9, 2021
Left Atrial Remodeling and Cerebrovascular Disease Assessed by Magnetic Resonance Imaging in Continuously Monitored PatientsLitten Bertelsen, Søren Zöga Diederichsen, Kristian Steen Frederiksen, et al.
Pageof 32

Showing results (281-290 of 313) with videos related to

Sort By:
Pageof 32
Heart Rhythm|July 19, 2015
Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit heartsYu-Cheng Hsieh, Jiunn-Cherng Lin, Chen-Ying Hung, et al.
Circulation. Arrhythmia and Electrophysiology|July 18, 2024
Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP StudyLucas Yixi Xing, Søren Højberg, Derk W Kriegerg, et al.
Plos One|July 19, 2023
Treatment-induced increase in total body potassium in patients at high risk of ventricular arrhythmias; a randomized POTCAST substudyUlrik Winsløw, Tharsika Sakthivel, Chaoqun Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2009
The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis modelEric I Rossman, Kun Liu, Gwen A Morgan, et al.
American Heart Journal|August 24, 2021
Atrial fibrillation burden and cognitive decline in elderly patients undergoing continuous monitoringMathias Pinto Bonnesen, Søren Zöga Diederichsen, Jonas L Isaksen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 18, 2021
Comparison of the three-level and the five-level versions of the EQ-5DAnne Simone Juhl Christiansen, Marie Louise Sletskov Møller, Christian Kronborg, et al.
Plos One|June 3, 2022
Potential role of conventional and speckle-tracking echocardiography in the screening of structural and functional cardiac abnormalities in elderly individuals: Baseline echocardiographic findings from the LOOP studyFlemming Javier Olsen, Søren Zöga Diederichsen, Peter Godsk Jørgensen, et al.
Journal of the American College of Cardiology|October 29, 2025
Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP StudyOliver B Vad, Søren Z Diederichsen, Lucas Y Xing, et al.
Circulation. Cardiovascular Imaging|March 5, 2024
Left Atrial Strain Predicts Subclinical Atrial Fibrillation Detected by Long-term Continuous Monitoring in Elderly High-Risk IndividualsFlemming Javier Olsen, Søren Zöga Diederichsen, Peter Godsk Jørgensen, et al.
Cerebrovascular Diseases (Basel, Switzerland)|December 9, 2021
Left Atrial Remodeling and Cerebrovascular Disease Assessed by Magnetic Resonance Imaging in Continuously Monitored PatientsLitten Bertelsen, Søren Zöga Diederichsen, Kristian Steen Frederiksen, et al.
Pageof 32